Publications found:
139
Sort by:
Sulfonylureas Market Size, Share and Growth Outlook 2026: By Drug Type (Glyburide, Glipizide, Glimepiride, Others), By Indication, By Dosage Form, By Route of Administration, By End-User, By Distribution Channel, Companies to 2034.
US$ 3,869.00
The global Sulfonylureas Market size is forecast to increase from $12.93 Billion in 2026 to $17.16 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034. The Sulfonylureas market report provides det...
July 2026
190 pages
South Korea Diabetes Drugs Market Report by Drug (Insulins, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, Combination Drugs), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and Region 2026-2034
US$ 2,999.00
South Korea diabetes drugs market size reached USD 1.90 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.90 Billion by 2034, exhibiting a growth rate (CAGR) of 11.31% du...
July 2026
115 pages
South Korea Oral Anti-Diabetic Drug Market Report by Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine D2 Receptor Agonist, SGLT-2 Inhibitors, DPP-4 Inhibitors, Sulfonylureas, Meglitinides), and Region 2026-2034
US$ 2,999.00
South Korea oral anti-diabetic drug market size reached USD 897.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,191.0 Million by 2034, exhibiting a growth rate (CAGR)...
July 2026
121 pages
Global Dual Incretin Agonists Market Size Study and Forecast by Drug (Tirzepatide, Survodutide, and Others), Disease Indication (Type 2 Diabetes, Obesity, MASH/NASH, and Others), Age Group (Pediatric and Adults), Type (Branded and Generics), Route of Administration (Subcutaneous, Oral, and Others), Distribution Channel, Regional Forecasts 2026-2036
US$ 3,750.00
The global dual incretin agonists market, valued at USD 36.51 billion in 2025, is anticipated to reach approximately USD 82.94 billion by 2036, growing at 7.75% CAGR during the forecast period. Dual i...
June 2026
285 pages
India GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide, Tirzepatide, Dulaglutide), By Application (Type 2 Diabetes Mellitus, Cardiovascular Risk), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The India GLP-1 receptor agonist market size was valued at USD 150.8 million in 2025 and is projected to grow from USD 240.5 million in 2026 to USD 1,004.9 million by 2033, at a CAGR of 22.7% from 202...
June 2026
150 pages
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (Biguanides, Alpha-glucosidase inhibitors, Dopamine -D2 Receptor Agonist, Sodium-glucose Cotransport -2 (SGLT-2) inhibitor, Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors, Sulfonylureas, Meglitinides), By End Users (Hospitals, Homecare, Speciality Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Anti-Diabetic Drugs Market is projected to expand significantly from USD 18.67 Billion in 2025 to USD 28.07 Billion by 2031, demonstrating a robust 7.03% CAGR. These orally administere...
May 2026
185 pages
Diabetic Gastroparesis Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Grade 2(Compensated Gastroparesis), Grade 3(Gastric Failure), By Drug Class (Gastroprokinetic Agents, Antiemetic Agents, Antihistamines, Others), By Route of Administration (Oral, Parenteral, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for diabetic gastroparesis treatments is projected to expand from USD 3.03 Billion in 2025 to USD 3.74 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 3.57%. This...
May 2026
180 pages
Insulin Aspart Market Size, Share & Trends Analysis Report By Product (Branded, Biosimilar), By Application (Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel (Hospital Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Insulin Aspart Market The global insulin aspart market size was estimated at USD 3,520.00 million in 2025 and is projected to reach USD 5,019.85 million by 2033, growing at a CAGR of 4.60% from 2026 t...
May 2026
150 pages
Rapid Acting Insulin Market Report by Product (Lispro Insulin, Aspart Insulin, Glulisine Insulin), Indication (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2026-2034
US$ 2,999.00
The global rapid acting insulin market size reached USD 8.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 11.7 Billion by 2034, exhibiting a growth rate (CAGR) of 3.74%...
April 2026
148 pages
Global Diabetes Drugs Market - 2025-2033
US$ 2,999.00
The Global Diabetes Drugs Market was valued at US$ 85.21 Billion in 2025 and is anticipated to reach US$ 125.36 Billion by 2033, at a CAGR of 0.0483 from 2026 to 2032. The report delivers in-depth ins...
March 2026
210 pages
GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide (Ozempic, Wegovy, Rybelsus), Tirzepatide), By Application, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global GLP-1 receptor agonist market size was estimated at USD 66.38 billion in 2025 and is projected to reach USD 185.32 billion by 2033, growing at a CAGR of 12.4% from 2026 to 2033. GLP-1 recep...
March 2026
150 pages
Global Sitagliptin Intermediates Market Growth 2026-2032
US$ 3,660.00
The global Sitagliptin Intermediates market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Sitagliptin intermediates...
March 2026
130 pages
